Dosage regimen for administering a CD19xCD3 bispecific antibody

Details for Australian Patent Application No. 2010311559 (hide)

Owner Micromet AG

Inventors Nagorsen, Dirk; Kufer, Peter; Zugmaier, Gerhard; Baeuerle, Patrick

Agent Pizzeys

Pub. Number AU-A-2010311559

PCT Pub. Number WO2011/051307

Priority 61/255,290 27.10.09 US; 09174104.1 27.10.09 EP

Filing date 27 October 2010

Wipo publication date 5 May 2011

International Classifications

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

5 April 2012 PCT application entered the National Phase

  PCT publication WO2011/051307 Priority application(s): WO2011/051307

20 September 2012 Alteration of Name

  The name of the applicant has been altered to Amgen Research (Munich) GmbH

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010311561-Method for the manufacture of phosphonoalkyl iminodiacetic acid

2010311547-Use of a metal supplement in animal feed